Vertex Reports Second-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints investors, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
Vertex Pharma (VRTX) Tops Q2 EPS by 54c, Revenues Beat; Raises FY20 Revenue Guidance
July 30, 2020 4:03 PM EDTVertex Pharma (NASDAQ: VRTX) reported Q2 EPS of $2.61, $0.54 better than the analyst estimate of $2.07. Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.39 billion.
"This has been an exceptional first half for Vertex on all fronts and most importantly, in our efforts to... More
